References
- DeFranco A L. Immunosuppressants at work. Nature 1991; 352: 754–755
- Flanagan W M, Corthesy B, Bram R J, Crabtree G R. Nuclear association of a T-cell transcription factor blocked by FK-506 and Cyclosporin A. Nature 1991; 352: 803–807
- Su M SS, Semerjian A. Activation of transcription factor nFkB in Jurkat cells is inhibited selectively by FK-506 in a signal dependent manner. Transpl Proc 1991; 23: 2912–2915
- Kimball P M, Kerman R H, Kahan B D. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine. Transplantation 1991; 54: 486–490
- Thomson A W. The spectrum of action of new immunosuppressive drugs. Clin Exp Immunol 1992; 89: 170–173
- Nussenblatt R B, Rook A H, Wacker W B, Palestine A G, Scher I, Gery I. Treatment of intraocular inflammatory disease with Cyclosporin A. Lancet 1983; 2: 235–238
- BenEzra D, Cohen E, Chajek T, Friedman G, Pizanti S, de Courten Ch, Harris W. Evaluation of conventional therapy versus Cyclosporin A in Behcet's syndrome. Transpl Proc 1988; 20: 136–143
- Mochizuki M, Masuda K, Sakane T, Inaba G, Ito K, Kogure M, et al. A multicenter clinical trial of FK506 in refractory uveitis. Transpl Proc 1991; 23: 3343–3346
- BenEzra D. A micro-culture technique for the evaluation of corneal cell metabolism in vitro. Invest Ophthalmol 1977; 16: 893–898
- BenEzra D. Possible regulatory mechanisms of the cornea: I. Epithelial-stromal interaction in vitro. Arch Ophthalmol 1978; 96: 1891–1896
- Nossal G JV. Summary of the first international FK506 congress: Prospectives and prospects. Transpl Proc 1991; 23: 3371–3375
- Palestine A G, Austin H A, Balow J E, Antonovych T T, Sabins S G, Preus H G, Nussenblatt R B. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med 1986; 314: 1293–1296
- BenEzra D, Nussenblatt R B, Timonen P. Optimal Use of Sandimmun in Endogenous Uveitis (monograph). Springer-Verlag, Berlin/Heidelberg/New York 1988; 1–22
- BenEzra D, Anteby I, Maftzir G. Differential effect of cyclosporin A on lymphocyte and keratocyte proliferation. Invest Ophthalmol Vis Sci 1987; 28: 42
- BenEzra D, Pe'er J, Brodsky M, Cohen E. Cyclosporine eye drops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol 1986; 101: 278–282
- BenEzra D, Maftzir G. Ocular penetration of cyclosporin A. The rabbit eye. Invest Ophthalmol Vis Sci 1990; 31: 1362–1366